8.05
Relay Therapeutics Inc 주식(RLAY)의 최신 뉴스
Relay Therapeutics stock hits 52-week high at $7.65 - Investing.com
Should I hold or sell Relay Therapeutics Inc. stock in 2025CEO Change & AI Based Buy and Sell Signals - newser.com
Key metrics from Relay Therapeutics Inc.’s quarterly data2025 Dividend Review & Technical Entry and Exit Alerts - newser.com
Is Relay Therapeutics Inc. stock a top momentum playJuly 2025 Drop Watch & Daily Market Momentum Tracking - newser.com
Relay Therapeutics Inc.’s volatility index tracking explainedJuly 2025 Price Swings & Capital Protection Trading Alerts - newser.com
Relay Therapeutics Inc. (RLAY) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Top 3 Biotech Stocks Capitalizing on the AI Revolution - Investing.com
Top 3 Biotech Stocks Capitalizing on the AI Revolution - Investing.com
Commit To Buy Relay Therapeutics At $5, Earn 22.4% Annualized Using Options - Nasdaq
Citizens reiterates Market Outperform rating on Relay Therapeutics stock By Investing.com - Investing.com Canada
What analysts say about Relay Therapeutics Inc stockChart Pattern Recognition & Outstanding Growth Strategies - earlytimes.in
How Relay Therapeutics Inc. stock compares to growth peersTrade Performance Summary & AI Optimized Trade Strategies - newser.com
Is Relay Therapeutics Inc. stock positioned for long term growth - newser.com
Does Relay Therapeutics Inc. show high probability of reboundProduct Launch & Reliable Price Action Trade Plans - newser.com
Backtesting results for Relay Therapeutics Inc. trading strategiesShare Buyback & Growth Focused Stock Reports - newser.com
Analyzing recovery setups for Relay Therapeutics Inc. investorsEarnings Performance Report & Risk Managed Investment Entry Signals - newser.com
Relay Therapeutics Q3 2025 Earnings Preview - MSN
Why Relay Therapeutics Inc. stock is trending among retail traders2025 Trading Recap & Free Community Supported Trade Ideas - Fundação Cultural do Pará
What machine learning models say about Relay Therapeutics Inc.2025 Investor Takeaways & Daily Entry Point Trade Alerts - newser.com
Why retail investors favor Relay Therapeutics Inc. stockQuarterly Market Summary & AI Enhanced Execution Alerts - newser.com
How to use a screener to detect Relay Therapeutics Inc. breakoutsShare Buyback & Safe Swing Trade Setups - newser.com
Will Relay Therapeutics (RLAY) Board Additions Signal a Shift in Commercialization Strategy? - Yahoo Finance
Relay Therapeutics Inc Stock Analysis and ForecastTrend Following Strategies & Minimal Capital Growth Plans - earlytimes.in
Regression analysis insights on Relay Therapeutics Inc. performanceDollar Strength & AI Powered Market Entry Ideas - newser.com
Using Ichimoku Cloud for Relay Therapeutics Inc. technicalsJuly 2025 PostEarnings & Safe Entry Trade Reports - newser.com
Why hedge funds are buying Relay Therapeutics Inc. stockMarket Volume Summary & Consistent Return Investment Signals - newser.com
Has Relay Therapeutics Inc. found a price floor2025 Trading Recap & Stock Portfolio Risk Control - newser.com
Relay Therapeutics Trims Costs And Stays Well-Funded - Finimize
Full technical analysis of Relay Therapeutics Inc. stockMarket Rally & Safe Entry Trade Reports - newser.com
Wells Fargo Maintains Relay Therapeutics (RLAY) Equal-Weight Recommendation - Nasdaq
Relay Therapeutics (RLAY) Analyst Rating Update by Wells Fargo | RLAY Stock News - GuruFocus
Relay Therapeutics Reports Q3 2025 Financial Progress - TipRanks
Decoding Relay Therapeutics Inc (RLAY): A Strategic SWOT Insight - GuruFocus
Relay Therapeutics to Announce Third Quarter 2025 Financial Results and Corporate Highlights on November 6, 2025 - Investing News Network
Relay Therapeutics (RLAY) Advances Clinical Trials in Breast Can - GuruFocus
Relay Therapeutics Reports Third Quarter 2025 Financial Results and Corporate Updates - Investing News Network
Relay Therapeutics Inc Reports Q3 2025 EPS of -$0.43, Revenue at $0, Missing Estimates - GuruFocus
Relay Therapeutics slightly misses Q3 net loss estimates, expects cash reserves to fund operations into 2029 - TradingView
Relay Therapeutics Appoints Two New Board Members - TradingView
[10-Q] Relay Therapeutics, Inc. Quarterly Earnings Report | RLAY SEC FilingForm 10-Q - Stock Titan
[8-K] Relay Therapeutics, Inc. Reports Material Event | RLAY SEC FilingForm 8-K - Stock Titan
RLAY: Clinical progress, reduced losses, and strong cash position support operations into 2029 - TradingView
자본화:
|
볼륨(24시간):